PlainRecalls
FDA Drug Moderate Class II Terminated

ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25

Reported: January 8, 2025 Initiated: December 19, 2024 #D-0173-2025

Product Description

ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25

Reason for Recall

Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

Details

Recalling Firm
Hikma Injectables USA Inc
Units Affected
1,800 syringes
Distribution
Nationwide in the USA
Location
Dayton, NJ

Frequently Asked Questions

What product was recalled?
ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25. Recalled by Hikma Injectables USA Inc. Units affected: 1,800 syringes.
Why was this product recalled?
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 8, 2025. Severity: Moderate. Recall number: D-0173-2025.